These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37990228)

  • 1. Clustering of lifestyle behaviours and analysis of their associations with MAFLD: a cross-sectional study of 196,515 individuals in China.
    Zhou B; Gong N; He Q; Huang X; Zhu J; Zhang L; Huang Y; Tan X; Xia Y; Zheng Y; Shi Q; Qin C
    BMC Public Health; 2023 Nov; 23(1):2303. PubMed ID: 37990228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of polychlorinated biphenyls and organochlorine pesticides with metabolic dysfunction-associated fatty liver disease among Chinese adults: Effect modification by lifestyle.
    Liu Q; Fan G; Bi J; Qin X; Fang Q; Wu M; Mei S; Wan Z; Lv Y; Song L; Wang Y
    Environ Res; 2024 Jan; 240(Pt 2):117507. PubMed ID: 37918764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease.
    Guo B; Guo Y; Nima Q; Feng Y; Wang Z; Lu R; Baimayangji ; Ma Y; Zhou J; Xu H; Chen L; Chen G; Li S; Tong H; Ding X; Zhao X;
    J Hepatol; 2022 Mar; 76(3):518-525. PubMed ID: 34883157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-specific prevalence and risk factors of metabolic-associated fatty liver disease among 75,570 individuals in eastern China.
    Chang M; Shao Z; Wei W; Shen P; Shen G
    Front Endocrinol (Lausanne); 2023; 14():1241169. PubMed ID: 37822594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary and Lifestyle Inflammation Scores Are Inversely Associated with Metabolic-Associated Fatty Liver Disease among Iranian Adults: A Nested Case-Control Study.
    Taheri E; Bostick RM; Hatami B; Pourhoseingholi MA; Asadzadeh Aghdaei H; Moslem A; Mousavi Jarrahi A; Zali MR
    J Nutr; 2022 Feb; 152(2):559-567. PubMed ID: 34791370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study.
    Chen YL; Li H; Li S; Xu Z; Tian S; Wu J; Liang XY; Li X; Liu ZL; Xiao J; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    BMC Gastroenterol; 2021 May; 21(1):212. PubMed ID: 33971822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthy dietary patterns and metabolic dysfunction-associated fatty liver disease in less-developed ethnic minority regions: a large cross-sectional study.
    Xie X; Guo B; Xiao X; Yin J; Wang Z; Jiang X; Li J; Long L; Zhou J; Zhang N; Zhang Y; Chen T; Kangzhuo B; Zhao X
    BMC Public Health; 2022 Jan; 22(1):118. PubMed ID: 35038997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: A community-based study.
    Zeng J; Qin L; Jin Q; Yang RX; Ning G; Su Q; Yang Z; Fan JG
    Hepatobiliary Pancreat Dis Int; 2022 Apr; 21(2):154-161. PubMed ID: 35153138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction and Validation of Metabolic Dysfunction-Associated Fatty Liver Disease Using Insulin Resistance-Related Indices in the Japanese Population.
    Moriyama K; Inoue N; Imai J; Masuda Y; Yamada C; Kishimoto N; Takashimizu S; Kubo A; Nishizaki Y
    Metab Syndr Relat Disord; 2023 Nov; 21(9):489-496. PubMed ID: 37878804
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China.
    Li H; Guo M; An Z; Meng J; Jiang J; Song J; Wu W
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32168920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Combined Lifestyle Factors with MAFLD and the Specific Subtypes in Middle-Aged and Elderly Adults: The Dongfeng-Tongji Cohort Study.
    Li H; Cao Z; Li J; King L; Zhang Z; Zhao Y; Zhang S; Song Y; Zhang Q; Chen L; Tang Y; Dai L; Yao P
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotemporal substitution of different behaviour patterns with the presence of MAFLD in Chinese adults.
    Wang J; Qi Y; Xin Z; Huo Y; Wan Q; Qin Y; Hu R; Shi L; Su Q; Yu X; Yan L; Qin G; Tang X; Chen G; Xu M; Xu Y; Wang T; Zhao Z; Gao Z; Wang G; Shen F; Luo Z; Chen L; Li Q; Ye Z; Zhang Y; Liu C; Wang Y; Yang T; Deng H; Chen L; Zeng T; Zhao J; Mu Y; Wu S; Chen Y; Lu J; Wang W; Ning G; Bi Y; Li M;
    Liver Int; 2022 Dec; 42(12):2683-2695. PubMed ID: 36166316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-Life Exposure to Famine and Risk of Metabolic Associated Fatty Liver Disease in Chinese Adults.
    Liu J; Wang G; Wu Y; Guan Y; Luo Z; Zhao G; Jiang Y
    Nutrients; 2021 Nov; 13(11):. PubMed ID: 34836318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep Factors in Relation to Metabolic Dysfunction-Associated Fatty Liver Disease in Middle-Aged and Elderly Chinese.
    Yang J; Luo S; Li R; Ju J; Zhang Z; Shen J; Sun M; Fan J; Xia M; Zhu W; Liu Y
    J Clin Endocrinol Metab; 2022 Sep; 107(10):2874-2882. PubMed ID: 35900115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between Healthy Lifestyle and All-Cause Mortality in Individuals with Metabolic Associated Fatty Liver Disease.
    Wang X; Wang A; Zhang R; Cheng S; Pang Y
    Nutrients; 2022 Oct; 14(20):. PubMed ID: 36296904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Socio-demographic association of multiple modifiable lifestyle risk factors and their clustering in a representative urban population of adults: a cross-sectional study in Hangzhou, China.
    Lv J; Liu Q; Ren Y; Gong T; Wang S; Li L;
    Int J Behav Nutr Phys Act; 2011 May; 8():40. PubMed ID: 21569614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle changes during the coronavirus disease 2019 pandemic impact metabolic dysfunction-associated fatty liver disease.
    Fujii H; Nakamura N; Fukumoto S; Kimura T; Nakano A; Nadatani Y; Tauchi Y; Nishii Y; Takashima S; Kamada Y; Watanabe T; Kawada N
    Liver Int; 2022 May; 42(5):995-1004. PubMed ID: 34995404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Establishment and Analysis of Risk Prediction Model for Metabolic Dysfunction-Associated Fatty Liver Disease in Physical Examination Population].
    Xia B; He H; Qin K; Li SQ; An ZM
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):591-595. PubMed ID: 37248589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017-2018.
    Liu J; Tang Y; Feng Z; Chen Y; Zhang X; Xia Y; Geng B
    Osteoporos Int; 2023 Apr; 34(4):713-724. PubMed ID: 36719471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Observational and Cross-Sectional Study of the Prevalence of Breast Lesions and Metabolic Dysfunction-Associated Fatty Liver Disease and their Relationship in China.
    Li S; Xu Z; Li H; Tang J; Liang XY; Tian S; Wu J; Li X; Liu ZL; Xiao J; Chen YL; Wei JY; Ma CY; Wu KN; Ran L; Kong LQ
    J Gastrointestin Liver Dis; 2022 Mar; 31(1):31-39. PubMed ID: 35306559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.